Plevy SE - Search Results

1

Morbidity of subtotal colectomy in patients with severe ulcerative colitis unresponsive to cyclosporin.

Fleshner PR, Michelassi F, Rubin M, Hanauer SB, Plevy SE, Targan SR. Fleshner PR, et al. Among authors: plevy se. Dis Colon Rectum. 1995 Dec;38(12):1241-5. doi: 10.1007/BF02049146. Dis Colon Rectum. 1995. PMID: 7497833

2

Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6.

Plevy SE, Targan SR, Yang H, Fernandez D, Rotter JI, Toyoda H. Plevy SE, et al. Gastroenterology. 1996 Apr;110(4):1053-60. doi: 10.1053/gast.1996.v110.pm8612993. Gastroenterology. 1996. PMID: 8612993

3

Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup.

Vasiliauskas EA, Plevy SE, Landers CJ, Binder SW, Ferguson DM, Yang H, Rotter JI, Vidrich A, Targan SR. Vasiliauskas EA, et al. Among authors: plevy se. Gastroenterology. 1996 Jun;110(6):1810-9. doi: 10.1053/gast.1996.v110.pm8964407. Gastroenterology. 1996. PMID: 8964407

4

A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease.

Plevy SE, Landers CJ, Prehn J, Carramanzana NM, Deem RL, Shealy D, Targan SR. Plevy SE, et al. J Immunol. 1997 Dec 15;159(12):6276-82. J Immunol. 1997. PMID: 9550432

5

Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses.

Yang H, Plevy SE, Taylor K, Tyan D, Fischel-Ghodsian N, McElree C, Targan SR, Rotter JI. Yang H, et al. Among authors: plevy se. Gut. 1999 Apr;44(4):519-26. doi: 10.1136/gut.44.4.519. Gut. 1999. PMID: 10075959 Free PMC article.

6

Crohn's disease-associated genetic marker is seen in medically unresponsive ulcerative colitis patients and may be associated with pouch-specific complications.

Facklis K, Plevy SE, Vasiliauskas EA, Kam L, Taylor K, Targan SR, Fleshner PR. Facklis K, et al. Among authors: plevy se. Dis Colon Rectum. 1999 May;42(5):601-5; discussion 605-6. doi: 10.1007/BF02234133. Dis Colon Rectum. 1999. PMID: 10344681

7

Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis.

Rowe FA, Walker JH, Karp LC, Vasiliauskas EA, Plevy SE, Targan SR. Rowe FA, et al. Among authors: plevy se. Am J Gastroenterol. 2000 Aug;95(8):2000-8. doi: 10.1111/j.1572-0241.2000.02186.x. Am J Gastroenterol. 2000. PMID: 10950049

8

Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease.

Cornillie F, Shealy D, D'Haens G, Geboes K, Van Assche G, Ceuppens J, Wagner C, Schaible T, Plevy SE, Targan SR, Rutgeerts P. Cornillie F, et al. Among authors: plevy se. Aliment Pharmacol Ther. 2001 Apr;15(4):463-73. doi: 10.1046/j.1365-2036.2001.00956.x. Aliment Pharmacol Ther. 2001. PMID: 11284774 Clinical Trial.

9

ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease.

Taylor KD, Plevy SE, Yang H, Landers CJ, Barry MJ, Rotter JI, Targan SR. Taylor KD, et al. Among authors: plevy se. Gastroenterology. 2001 May;120(6):1347-55. doi: 10.1053/gast.2001.23966. Gastroenterology. 2001. PMID: 11313304 Clinical Trial.

10

A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis.

Plevy S, Salzberg B, Van Assche G, Regueiro M, Hommes D, Sandborn W, Hanauer S, Targan S, Mayer L, Mahadevan U, Frankel M, Lowder J. Plevy S, et al. Gastroenterology. 2007 Nov;133(5):1414-22. doi: 10.1053/j.gastro.2007.08.035. Epub 2007 Aug 21. Gastroenterology. 2007. PMID: 17920064 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters